Pulmonary function after COVID-19 in early convalescence phase
https://doi.org/10.33667/2078-5631-2020-25-7-12
Abstract
Pulmonary function after COVID-19 in early convalescence phase. The aim of the study is to investigate the influence of Coronavirus disease 2019 (COVID-19) on pulmonary function in early convalescence phase.
Materials and methods. The study included 44 patients (35 male) after COVID-19 without concomitant bronchopulmonary pathology, with a median age of 47.5 years. All patients underwent standard pulmonary function tests (PFTs): spirometry, body plethysmography, diffusion test. Besides, dyspnea on the mMRC scale was assessed, oxygen saturation level (SpO2 ) was measured. Depending on degree of lung damage determined using high-resolution computed tomography (CT), the patients were divided into 2 groups: group 1 (22 patients) — CT 1 and CT 2, group 2 (22 patients) — CT 3 and CT 4.
Results. The medians of standard PFTs parameters were in normal values. However, there were statistically significant differences between groups: VC, FVC, FEV1 and TLC were lower in second group. Diffusing capacity was reduced in 52% of patients. Statistical significant correlations were established between lung damage by CT and the parameters of VC, FVC, FEV1 , TLC, IC and DLCO.
Conclusion. The degree of functional disorders of lungs depended on the extent of abnormal CT. Impaired diffusing capacity were detected in more than half of the COVID-19 patients in early convalescence phase.
About the Authors
O. I. SavushkinaRussian Federation
A. V. Cherniak
Russian Federation
E. V. Kryukov
Russian Federation
I. Ts. Kulagina
Russian Federation
M. V. Samsonova
Russian Federation
E. N. Kalmanova
Russian Federation
K. A. Zykov
Russian Federation
References
1. World Health Organization. Coronavirus disease (COVID-19) pandemic. URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
2. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Временные методические рекомендации Министерства здравоохранения Российской Федерации. Версия 7.0 (03.06.2020). URL: https://minzdrav.gov.ru/news/2020/06/03/14109- minzdrav-rossii-utverdil-7-versiyu-metodicheskih-rekomendatsiy-polecheniyu-covid-19.
3. Самсонова М.В., Михалева Л.М., Зайратьянц О.В., Варясин В.В., Быканова А.В., Мишнев О.Д., Березовский Ю.С., Тишкевич О.А., Гомзикова Е.А., Черняев А.Л., Хованская Т.Н. Патология легких при COVID-19 в Москве. // Архив патологии. — 2020. — Т.82, №3. — С.32–40. doi:10.17116/patol20208204132.
4. WölfelR., Corman V.M, Guggemos W, Seilmaier M, Zange S, Müller MA, Niemeyer D, Jones TC, Vollmar P, Rothe C, Hoelscher M, Bleicker T, Brünink S, Schneider J, Ehmann R, Zwirglmaier K, Drosten C, Wendtner C. Virological assessment of hospitalized patients with COVID-2019.// Nature. — 2020. — 581 (7809). — 465-469. doi: 10.1038/s41586–020–2196-x.
5. Huang Y., Tan C., Wu J., Chen M., Wang Z., Luo L., Zhou X., Liu X., Huang X., Yuan S., Chen Ch., Gao F., Huang J., Shan H., Liu J. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. // Respir. Res. — 2020. — Vol.21, №1. — Р.163. doi:10.1186/s12931–020–01429–6.
6. Mo X., Jian W., Su Z., Chen M., Peng H., Peng P., Lei Ch., Chen R., Zhong N., Li S. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. // Eur. Respir. J. — 2020. — Vol.55. — P.2001217. doi.10.1183/13993003.01217–2020.
7. Баклаушев В.П., Кулемзин С.В., Горчаков А.А. Лесняк В.Н., Юсубалиева Г.М., Сотникова А. Г. COVID-19. Этиология, патогенез, диагностика и лечение. // Клиническая практика. —2020. Т.11,№1. — С.7–20. doi: 10.17816/clinpract26339.
8. Чучалин А. Г., Айсанов З. Р., Чикина С.Ю. Черняк А. В., Калманова Е.Н. Федеральные клинические рекомендации Российского респираторного общества по использованию метода спирометрии. // Пульмонология. — 2014. — №6. — С.11–23.
9. Graham B. L., Steenbruggen I., Miller M. R., Burgos F., Casaburi R., Coates A., Crapo R., Enright P., van der Grinten C.P., Gustafsson P., Jensen R., Johnson D.C., MacIntyre N., McKay R., Navajas D., Pedersen O.F., Pellegrino R., Viegi G., Wanger J.; ATS/ERS Task Force. Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement.// Am. J. Respir. Crit. Care Med. — 2019. — Vol.200,№8. — P. e70 – e88. doi: 10.1164/rccm.201908–1590ST.
10. Wanger J., Clausen J.L., Coates A., Pedersen O.F., Brusasco V., Burgos F., Casaburi R., Crapo R., Enright P., van der Grinten C.P., Gustafsson P., Hankinson J., Jensen R., Johnson D., Macintyre N., McKay R., Miller M.R., Navajas D., Pellegrino R., Viegi G. Standardisation of the measurement of lung volumes. // Eur. Respir. J. — 2005. — Vol.26,№3. — Р.511–522. doi: 10.1183/09031936.05.00035005.
11. Graham B.L., Brusasco V., Burgos F., Cooper B.G., Jensen R., Kendrick A., MacIntyre N.R., Thompson B.R., Wanger J. 2017 ERS/ATS Standards for single-breath carbon monoxide uptake in the lung. // Eur. Respir.J. — 2017. — Vol.49. — P.pii: 1600016. doi: 10.1183/13993003.00016-2016.
12. Рекомендации Российского респираторного общества по проведению функциональных исследований системы дыхания в период пандемии COVID-19 Версия 1.1. от 19.05.2020. URL: https://spulmo.ru/upload/rekomendacii_rro_fvd_COVID_19_ rev1_1_01062020.pdf.
13. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., Yernault J.C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. // Eur. Respir. J. —1993. — Vol.6 (Suppl.16). — P.5–40.
14. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Zh., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo Li, Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. // Lancet. — 2020. — Vol.395. — P.497–506. doi: 10.1016/S0140–6736(20)30183–5.
15. Li L., Huang T., Wang Y., Wang Z., Liang Y., Huang T., Zhang H., Sun W., Wang Y.СOVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. // J. Med.Virol. 2020. — Vol.92,№6. — Р.577-583. doi: 10.1002/jmv.25757.
16. Lippi G., Henry B.M. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). // Eur. J. Intern. Med. — 2020. — Vol.75. — P.107–108. doi: 10.1016/j.ejim.2020.03.014.
17. Rossato M., Russo L., Mazzocut S., DiVincenzo A., Fioretto P., Vettor R. Current smoking is not associated with COVID-19. //Eur. Respir. J. —2020. —Vol.55. — P.2001290. doi:10.1183/13993003.01290–2020.
Review
For citations:
Savushkina O.I., Cherniak A.V., Kryukov E.V., Kulagina I.Ts., Samsonova M.V., Kalmanova E.N., Zykov K.A. Pulmonary function after COVID-19 in early convalescence phase. Medical alphabet. 2020;(25):7-12. (In Russ.) https://doi.org/10.33667/2078-5631-2020-25-7-12